[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100146546":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":18,"centralContacts":10,"locations":23,"responsibleParty":10,"collaborators":10,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":40,"acronym":10,"eligibilityCriteria":41,"healthyVolunteers":37,"sex":42,"minAge":43,"maxAge":44,"enrollmentInfo":10,"targetDuration":10,"studyType":45,"phases":46,"briefSummary":48,"conditions":49,"keywords":52,"overallStatus":55,"whyStopped":10,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":10,"leadSponsor":62,"locationsCount":63},{"fullName":5,"class":6},"University Hospital Tuebingen","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Mother CMV positive",null,[12],"Procedure: ultrashort heat inactivation",[14],{"type":15,"name":16,"description":10,"armGroupLabels":17,"otherNames":10},"PROCEDURE","ultrashort heat inactivation",[9],[19],{"name":20,"affiliation":21,"role":22},"Rangamr Goelz, MD","Tuebingen University Hospital","PRINCIPAL_INVESTIGATOR",[24],{"facility":21,"status":10,"city":25,"state":10,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":10},"Tübingen","72070","Germany","DE",{"type":30,"coordinates":31},"Point",[32,33],9.05222,48.52266,{"lat":33,"lon":32},"100146546","clinical-evaluation-of-ultrashort-term-heat-inactivation-of-cytomegalovirus-cmv-containing-raw-breast-milk-to-prevent-cmv-infection-of-preterm-infants-100146546",false,"NCT01178905","Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants","Clinical Evaluation of a Gentle But Safe Ultrashort-term Heat Inactivation Procedure of Raw Breast Milk (BM) Containing Virulent Cytomegalovirus for Preventing CMV-infection of Preterm Infants","Inclusion Criteria:\n\n* \\\u003C32 Weeks or GA or \\\u003C1500g BW\n* mother CMV IgG positive\n* breast milk feeding\n\nExclusion Criteria:\n\n* parents disagree","ALL","23 Weeks","40 Weeks","INTERVENTIONAL",[47],"NA","To evaluate, in a prospective multicenter study, ultrashort-term heat inactivation for the prevention of Cytomegalovirus (CMV) transmission in preterm infants (\\\u003C32 weeks gestational age or \\\u003C1500 g birth weight) under clinical conditions. Inactivation will be done only during the period of infectivity of breast milk, characterized by viral excretion strongly associated with subsequent infection, monitored by periodic virologic examinations of BM and urine of the infant. Thus the investigators hypothesis is that no CMV transmission through breast milk will occur using a gentle ultrashort heat inactivation procedure applied to infective breast milk.\n\nThe protocol has been approved by the ethics committee of Tuebingen University Hospital.",[50,51],"Cytomegalovirus Infection","Preterm Infants",[53,54],"Postnatal CMV infection of preterm infants","breast milk","COMPLETED","2013-04-23",{"date":58,"type":59},"2013-04-24","ESTIMATED",{"date":61,"type":10},"2010-08",{"name":5,"class":6},1]